Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenocarcinoma. The gene discussed is AKT2; the disease is pancreatic ductal adenocarcinoma.